老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Annovis Bio, Inc.

1.60
+0.02001.27%
盘后：1.600.00000.00%18:12 EDT
成交量：29.93万
成交额：48.04万
市值：3,117.80万
市盈率：-0.69
高：1.68
开：1.58
低：1.56
收：1.58
数据加载中...
总览公司新闻公告
2021/03/03

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/09

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/20

超过5%披露

General statement of acquisition of beneficial ownership
2020/04/03

重要事件披露

Current report, item 8.01
2020/03/25

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/06

重要事件披露

Current report, items 5.03 and 9.01
2020/01/30

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

SEC问询函

[Cover]Correspondence
2020/01/24

SEC问询函

[Cover]Correspondence
2020/01/24

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/21

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
更多